Clinical Trial Update: Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma [Phase 3]

View source ↗

Summary

Phase 3 trial update for Fianlimab in combination with Cemiplimab versus Pembrolizumab in adolescent and adult patients with previously untreated unresectable l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Cemiplimab (cemiplimab)
• Fianlimab (fianlimab)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Melanoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING